EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0. It has been cited 61 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Leukemia and Lymphoma Society
Grant: 7029-23
Gilead Research Scholars
Grant: GSI 231647-01
Gilead Research Scholars
Grant: LLS CDP 3426-24
National Cancer Institute
Grant: R21 CA277513
Cycle for Survival
Grant: LLS SCOR 7021-20
Cycle for Survival
Grant: 7027-23